Aardvark Therapeutics Inc. – Filings and Transcripts

NASDAQ: AARD
Share price (6/1/26): $3.99
Market cap (6/1/26): $87.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

News Filter

Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold

Reports First Quarter 2026 Financial Results and Provides Business Updates

Material Definitive Agreement, Financial Statements or Exhibits

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness